Pamela Moalli
Urogynecology and Reconstructive Pelvic Surgery · Pittsburgh, PANPI 1912971672
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,625 of the $10,238 with a category attached, or 94.0%. 3 manufacturers reported payments, led by Hologic Sales And Service, LLC at 50.2% of the total.
Across 5 payments — averaging $2047.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$5K
- Cytyc Surgical Products, LLC$5K
- Applied Medical Resources Corporation$28
Across 3 payments — averaging $20,439 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$46K
- Tepha Inc$16K
What the payments were for
- Consulting fees$9,62594%
- Travel & lodging$5866%
- Food & beverage$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 3 | $5,136 |
| Cytyc Surgical Products, LLC | 1 | $5,075 |
| Applied Medical Resources Corporation | 1 | $28 |
How this compares
$10,238 in reported general payments places this provider in the 80th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.
See all urogynecology and reconstructive pelvic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 163 | $110,445 |
| Mirabegron ErMirabegron | 56 | $25,839 |
| PremarinEstrogens, Conjugated | 54 | $23,491 |
| Estradiol | 293 | $23,332 |
| GemtesaVibegron | 35 | $22,875 |
| Methenamine Hippurate | 214 | $14,983 |
| Trospium Chloride ErTrospium Chloride | 69 | $12,992 |
| EstringEstradiol | 11 | $5,578 |
| Desonide | 11 | $1,387 |
| Trospium Chloride | 33 | $1,110 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 77 | $716 |
| Sodium Bicarbonate | 11 | $530 |
| Clobetasol Propionate | 24 | $313 |
| Nystatin | 27 | $299 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Pittsburgh
- Allan KlapperPittsburgh$10K
- Lia MiceliPittsburgh$5K
- Jocelyn FitzgeraldPittsburgh$4K
- Radhika PatnamPittsburgh$1K
- Lauren GiugalePittsburgh$865
- Amanda ArtsenPittsburgh$459
- Ashley MurilloPittsburgh$308
- Halina ZyczynskiPittsburgh$190
- Mary AckenbomPittsburgh$132
- Lindsay TurnerPittsburgh$97
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.